Evidence map›Paper›PMID 41567599›Full record

ArticleEndoscopy international open2025

Clinical outcomes of circumferential endoscopic submucosal dissection in esophageal squamous cell carcinoma > 50 mm: Retrospective cohort study.

Takakazu Miyake, Hiroaki Takahashi, Satoshi Okahara, Ayumu Takizawa, Takashi Yokoyama, Junichi Kodaira, Keisuke Ishigami, Shinji Yoshii, Hiroshi Nakase

Abstract read
In one paragraph

Article in Endoscopy international open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Takakazu MiyakeDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University, Graduate School of Medicine, Sapporo, Japan.ORCID 0000-0003-4918-7243
Hiroaki TakahashiDepartment of Gastroenterology, Keiyukai Daini Hospital, Sapporo, Japan.
Satoshi OkaharaDepartment of Gastroenterology, Keiyukai Daini Hospital, Sapporo, Japan.
Ayumu TakizawaDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University, Graduate School of Medicine, Sapporo, Japan.
Takashi YokoyamaDepartment of Gastroenterology, Keiyukai Daini Hospital, Sapporo, Japan.
Junichi KodairaDepartment of Gastroenterology, Keiyukai Daini Hospital, Sapporo, Japan.
Keisuke IshigamiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University, Graduate School of Medicine, Sapporo, Japan.
Shinji YoshiiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University, Graduate School of Medicine, Sapporo, Japan.
Hiroshi NakaseDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Sapporo Medical University, Graduate School of Medicine, Sapporo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and study aims: This study aimed to assess both short-term safety and long-term outcomes of whole circumferential endoscopic submucosal dissection (WC-ESD) for esophageal squamous cell carcinoma (ESCC) with tumor length > 50 mm, and to evaluate effectiveness of aggressive prophylactic dilation combined with steroid therapy in preventing esophageal stricture. Patients and methods: A retrospective review was conducted on 67 patients who underwent WC-ESD for superficial ESCC between 2009 and 2019 at a single Japanese center. Patients were categorized into > 50-mm and ≤ 50-mm groups. The primary endpoint was incidence of post-ESD stricture in the main analysis excluding surgery/chemoradiotherapy cases within 90 days; sensitivity analysis included all patients. Secondary endpoints were number of dilations, steroid use, and long-term survival outcomes (overall survival [OS], disease-specific survival [DSS], relapse-free survival [RFS]). Results: Stricture incidence was not significantly different (> 50 mm vs. ≤ 50 mm: 13% vs. 18%, Conclusions: WC-ESD for superficial ESCC with a tumor length > 50 mm did not increase adverse events and provided comparable long-term survival. These findings support feasibility beyond guideline limits and emphasize further refinement of stricture prevention.

Indexed as

Barrett's and adenocarcinomaDilation, injection, stentingEndoscopic resection (ESD, EMRc, ...)Endoscopy Upper GI Tract

Identifiers

PMID41567599
PMCPMC12818186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.